Literature DB >> 8642648

Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.

Y Yamashita1, K Shimokata, S Mizuno, T Daikoku, T Tsurumi, Y Nishiyama.   

Abstract

Human cytomegalovirus glycoprotein B (gB) is synthesized as a 105-kDa nonglycosylated polypeptide and cotranslationally modified by addition of N-linked oligosaccharides to a 160-kDa precursor in the endoplasmic reticulum (ER). It is then transported to the Golgi complex, where it is endoproteolytically cleaved to form the disulfide-linked mature gp55-116 complex. Pulse-chase experiments demonstrate that the 160-kDa gB precursor was transiently associated with calnexin, a membrane-bound chaperone, in the ER. The association was maximal immediately after synthesis, and they dissociated with a half-time of 15 min. Complete inhibition of binding by tunicamycin or castanospermine indicates the importance of N-linked oligosaccharides for it. Nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated that during an initial stage in the biogenesis, the 160-kDa gB precursor was first synthesized as a fully reduced form and rapidly converted to an oxidized form, with a half-time of 18 min. Both forms of the gB precursor could bind to calnexin. The kinetics of the conversion from the fully reduced to the oxidized form coincided with that of dissociation of the 160-kDa gB precursor from calnexin, suggesting that the two steps are closely related.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642648      PMCID: PMC190064     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Protein oligomerization in the endoplasmic reticulum.

Authors:  S M Hurtley; A Helenius
Journal:  Annu Rev Cell Biol       Date:  1989

2.  The cyclophilin homolog ninaA is a tissue-specific integral membrane protein required for the proper synthesis of a subset of Drosophila rhodopsins.

Authors:  M A Stamnes; B H Shieh; L Chuman; G L Harris; C S Zuker
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

Review 3.  Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins.

Authors:  R B Freedman
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

Review 4.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 5.  Regulation of protein export from the endoplasmic reticulum.

Authors:  J K Rose; R W Doms
Journal:  Annu Rev Cell Biol       Date:  1988

6.  Characterization of a human cytomegalovirus glycoprotein complex (gcI).

Authors:  D R Gretch; R C Gehrz; M F Stinski
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

7.  CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.

Authors:  M J Reddehase; W Mutter; K Münch; H J Bühring; U H Koszinowski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.

Authors:  W J Britt; L G Vugler
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

9.  Intracellular folding of tissue-type plasminogen activator. Effects of disulfide bond formation on N-linked glycosylation and secretion.

Authors:  S Allen; H Y Naim; N J Bulleid
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

10.  Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules.

Authors:  E Degen; D B Williams
Journal:  J Cell Biol       Date:  1991-03       Impact factor: 10.539

View more
  13 in total

1.  Production of infectious human cytomegalovirus virions is inhibited by drugs that disrupt calcium homeostasis in the endoplasmic reticulum.

Authors:  Jennifer A Isler; Tobi Goldberg Maguire; James C Alwine
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells.

Authors:  S Tugizov; E Maidji; J Xiao; Z Zheng; L Pereira
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins.

Authors:  A Choukhi; S Ung; C Wychowski; J Dubuisson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.

Authors:  Kevin Whitby; Theodore C Pierson; Brian Geiss; Kelly Lane; Michael Engle; Yi Zhou; Robert W Doms; Michael S Diamond
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.

Authors:  M T Huber; T Compton
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.

Authors:  J Singh; T Compton
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles.

Authors:  S Laquerre; D B Anderson; R Argnani; J C Glorioso
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding.

Authors:  Z Zheng; E Maidji; S Tugizov; L Pereira
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Transient association of calnexin and calreticulin with newly synthesized G1 and G2 glycoproteins of uukuniemi virus (family Bunyaviridae).

Authors:  J Veijola; R F Pettersson
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 10.  Biochemistry and pathology of radical-mediated protein oxidation.

Authors:  R T Dean; S Fu; R Stocker; M J Davies
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.